NCT06520891View on ClinicalTrials.gov

"The Effect of The Combination Therapy of Statin and SGLT2i in The Treatment of Ischemic Heart Disease"

RecruitingOBSERVATIONAL

Enrollment

90

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

December 30, 2025

Conditions

2 Drugs Are Statin and SGLT2i

Interventions

DRUG

Statin and SGLT2i

Statin as atrovastatin SGLT2i as dapagliflozin

Trial Locations (1)

Unknown

RECRUITING

Asmaa mohamed abdelkader, Al Fayyum

All Listed Sponsors

lead

Fayoum University

OTHER